Skip to main content

Infant, Low Birth Weight

0
Pipeline Programs
4
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Eagle Pharmaceuticals
Eagle PharmaceuticalsNJ - Woodcliff Lake
1 program
Liquefied petroleum gasN/A
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
1 program
Liquefied petroleum gasN/A1 trial
Active Trials
NCT02944682Completed3,640Est. Jun 2025
Genentech
GenentechCA - Oceanside
1 program
epoetin betaN/A1 trial
Active Trials
NCT00593801Completed219Est. Jun 1999
Roche
RocheSTAVANGER NORWAY, Norway
1 program
epoetin betaN/A

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Colorado TherapeuticsLiquefied petroleum gas
Genentechepoetin beta

Clinical Trials (2)

Total enrollment: 3,859 patients across 2 trials

NCT02944682Colorado TherapeuticsLiquefied petroleum gas

Household Air Pollution and Health: A Multi-country LPG Intervention Trial

Start: Sep 2017Est. completion: Jun 20253,640 patients
N/ACompleted

Erythropoietin Treatment in Extremely Low Birth Weight Infants

Start: May 1998Est. completion: Jun 1999219 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.